• NPPA'S HELPLINE NO. 1800111255

Press Release/Explanatory Note

F.No. 8(41)/2002-DP/NPPA-Div.-II

National Pharmaceutical Pricing Authority
Ministry of Chemicals & Fertilizers
Government of India

2E/21, Jhandewalan Extn.,
New Delhi-110 055

Dated : 21st June, 2002

Explanatory Note

The National Pharmaceutical Pricing Authority has revised/fixed the prices of 14 formulation packs on June 21, 2001. Prices have been fixed for the first time in the case of 2 formulation packs. In the case of 12 packs, prices have been increased, ranging from 4.92% to 23.40%.

In all the 14 cases Non-ceiling prices have been fixed. Prices have been fixed/revised in accordance with the provisions of the DPCO, 1995 and as per the established criteria and guidelines. A copy of the statement showing the existing (where available) and revised prices is enclosed herewith. The information is also available on NPPA’s website www.nppaindia.nic.in.

The formulations for which prices have been revised/fixed includes formulation containing Methyl Prednisolone which are used as cortico-steriod medicines and Insulin based formulations which are used in the treatment of diabities.

The prices fixed/revised would become effective within 15 days from the date of notification in the official gazette or the receipt of the order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995.  Necessary revised price list is to be issued by the manufacturers/importers required under sub paragraph (3) of paragraph 14 of the DPCO, 1995.  Accordingly, as per the provisions of the DPCO, the revised price list in Form-V is to be furnished by the concerned manufacturer(s) to the government/NPPA, State Drug Control Authorities and distributors, wholesalers and retailers, etc.

The manufacturers are also required to work out the pro-rata prices of different pack sizes as the case may be in terms of S.O. No. 83 (E) dated 27.01.98.


Dy. Director

Last Page Updated: 31-05-2019